5-amino-1mq clinical trial human NNMT Inhibitor for Research Reduced calorie diet combined with

NNMT catalyzes transfer of a methyl group from S-adenosyl-L-methionine (SAM) to nicotinamide, producing 1-methylnicotinamide (1-MNA) and S-adenosyl-L-homocysteine

There may be temporary pain and discomfort during the IM injection itself, but these tend to ease quite quickly

Medical supervision, quality product sourcing, and realistic expectations are essential for safe and effective use

There is no proven human timeline for 5-Amino-1MQ

The peptide comes as lyophilized powder requiring reconstitution with bacteriostatic water before use

It exhibits an IC 50 of approximately 1 M for NNMT inhibition 4 , with favorable pharmacokinetic properties